Randomized controlled trial of molnupiravir SARS-CoV-2 viral and antibody response in at-risk adult outpatients. (2024)

First Author: Standing JF
Attributed to:  Mathematical and Statistical Modelling to Optimise Paediatric Medicines Research funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1038/s41467-024-45641-0

PubMed Identifier: 38396069

Publication URI: http://europepmc.org/abstract/MED/38396069

Type: Journal Article/Review

Volume: 15

Parent Publication: Nature communications

Issue: 1

ISSN: 2041-1723